Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Zentralbl Chir ; 139 Suppl 2: e55-62, 2014 Dec.
Article in German | MEDLINE | ID: mdl-23460109

ABSTRACT

BACKGROUND: Multimodal treatment options for ultra-low neoplasms of the rectum or anal cancer include chemotherapy, radical abdominoperineal resection and/or radiation. Primary wound closure increases the risk of perineal wound complications that require secondary revision. Perineal wound complications may trigger delay of adjacent tumor therapy and thus have an impact on rate of local recurrence and long-term survival for rectal cancer. Simultaneous primary reconstruction of the perineal defect has been shown to reduce the incidence of perineal wound complications as well as hospital stay which enables timely adjacent therapy and may improve prognosis. PATIENTS AND METHODS: This study was designed to retrospectively evaluate wound complications after abdominoperineal resection by comparing a group with and one without primary perineal reconstruction. Between 2005 and 2011, patients were analysed and divided into cohorts 1 and 2. Cohort 1 included n = 33 patients without primary perineal reconstruction. Cohort 2 included n = 4 patients with primary perineal reconstruction. Risk factors were identified for increased wound complications and delay of adjacent therapy. RESULTS: Subgroup analysis revealed that 18 out of 33 patients of cohort 1 had wound complications. In five cases, prolonged wound healing resulted in a delay of adjacent therapies. Four patients suffered from progression of tumour, 2 out of these 4 patients had a history of delayed adjacent therapy. The main risk factor for prolonged wound healing due to postoperative complications was a history of neoadjuvant treatment resulting in a rate of 64.7 %. Cohort 2 undergoing primary reconstruction presented without wound complications or delay in adjuvant therapy. DISCUSSION: A primary perineal reconstruction after APRE can reduce the rate of perineal wound complications. Furthermore, neoadjuvant treatment was shown to carry a major risk for wound complications. Patients after radio-/chemotherapy should undergo a primary reconstruction to prevent procedure-related perioperative morbidity. Subsequently, delays in adjuvant therapy, and prolonged hospital stay can be inhibited. Moreover, quality of life can be increased. The interdisciplinary approach aims at identifying high-risk patients for perineal wound complications who may benefit from primary reconstruction in order to reduce rate of wound complications with potential impact on rate of local recurrence. All these measures contribute to an optimized surgical standard.


Subject(s)
Abdomen/surgery , Anus Neoplasms/surgery , Cooperative Behavior , Interdisciplinary Communication , Perineum/surgery , Plastic Surgery Procedures/methods , Postoperative Complications/prevention & control , Rectal Neoplasms/surgery , Wound Healing/physiology , Aged , Aged, 80 and over , Anus Neoplasms/diagnosis , Anus Neoplasms/pathology , Chemoradiotherapy , Cohort Studies , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Rectal Neoplasms/diagnosis , Rectal Neoplasms/pathology , Retrospective Studies
2.
Eur Surg Res ; 47(1): 19-25, 2011.
Article in English | MEDLINE | ID: mdl-21540615

ABSTRACT

BACKGROUND: Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) can improve the prognosis of selected patients with peritoneal surface malignancy (PSM). Usually, treatment is performed as an extensive one-step approach. We investigated the feasibility of delayed HIPEC, if the one-step procedure was interrupted precociously. METHODS: 42 patients with PSM who underwent CRS and delayed HIPEC from 2006-2008 were studied. HIPEC was performed 5 days after treatment with mitomycin, cisplatin and hyperthermia. Perioperative complications and toxicity were analyzed. RESULTS: Delayed HIPEC was successfully completed in 40 of the 42 patients. In 2 cases, HIPEC was omitted because of complications during chemotherapy (anastomotic leakage and retroperitoneal edema). Minor and major surgical complications occurred in 18 and 9 of the 40 patients treated with HIPEC (45 vs. 22.5%), respectively. Toxicity grade II-IV (WHO criteria) was observed in 4 of them (10%). Median stay in the intensive care unit was 9 days (range 2-31) while the mean hospitalization time was 24 days (range 14-59). In this series, there was no mortality. CONCLUSION: Postponement of HIPEC after CRS (two-step approach) is feasible. Analysis of morbidity and mortality showed no significant difference to the one-step approach reported in the literature and no disadvantages for the patient. The two-step approach is an alternative option for patients who had to discontinue the one-step approach due to unpredictable intraoperative complications.


Subject(s)
Chemotherapy, Cancer, Regional Perfusion/methods , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/surgery , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cisplatin/administration & dosage , Combined Modality Therapy , Female , Humans , Hyperthermia, Induced/methods , Intraoperative Complications/etiology , Male , Middle Aged , Mitomycin/administration & dosage , Peritoneal Neoplasms/therapy , Prognosis , Retrospective Studies , Time Factors , Treatment Outcome
3.
Zentralbl Chir ; 136(4): 386-90, 2011 Aug.
Article in German | MEDLINE | ID: mdl-21341181

ABSTRACT

INTRODUCTION: After ilioinguinal radical lymph node dissection (RLND), the therapy for lymph fistulas constitutes a challenge. Risk factors for the genesis of lymph fistulas have not been sufficiently evaluated. We investigated possible factors that could influence the development of lymph fistulas in patients suffering from malignant melanoma after iloinguinal RLND. PATIENT AND METHODS: The analysis was related to patients with intransit and lymphonodal metastasised malignant melanoma of the lower limb, who underwent RLND and isolated limb perfusion (ILP). Prospective data acquisition from patients undergoing ilioinguinal RLND and ILP in a one-step approach was performed. The association of lymph fistulas to risk factors was calculated using chi-squared, linear-by-linear test and ROC curves. As possible risk factors we investigated the presence of prior surgery and diabetes mellitus type II in the medical history, chemotherapeutics, patient age and the body mass index (BMI). RESULTS: Postoperative lymph fistula occurred in 11 of 108 patients (10.2%). A significant association to lymph fistulas was found in BMI (30.2± 7.0 kg/m (2), p<0.02). Other parameters, such as prior surgery (82% vs. 71%), diabetes mellitus type II (9% vs. 11.7%), chemotherapeutics and patient age (mean 67.8 vs. 62.4 years) showed no influence. CONCLUSION: Our results indicate that the incidence of lymph fistulas after RLND and ILP of malignant melanoma of the lower limb was associated with an increased BMI. Thus, for the prevention of lymph fistulae, an initially alternative wound-closure dressing like vacuum assisted closure (V.A.C.) dressing could be of clinical relevance for obese patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemotherapy, Cancer, Regional Perfusion/adverse effects , Fistula/etiology , Leg , Lymph Node Excision/adverse effects , Lymphatic Diseases/etiology , Melanoma/drug therapy , Skin Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Body Mass Index , Chemotherapy, Adjuvant , Female , Humans , Inguinal Canal/surgery , Lymphatic Diseases/pathology , Lymphatic Diseases/prevention & control , Male , Melanoma/pathology , Melanoma/prevention & control , Melphalan/administration & dosage , Melphalan/adverse effects , Middle Aged , Negative-Pressure Wound Therapy , Neoplasm Staging , Obesity/complications , Postoperative Complications/etiology , Retrospective Studies , Risk Factors , Skin Neoplasms/pathology , Tumor Burden , Tumor Necrosis Factor-alpha/administration & dosage
4.
Chirurg ; 82(8): 714-8, 2011 Aug.
Article in German | MEDLINE | ID: mdl-21290093

ABSTRACT

Sclerosing angiomatoid nodular transformation (SANT) is a benign lesion of the spleen which can be cured by splenectomy. In the literature about 45 cases have been reviewed. Although it is defined by the morphological details, data regarding surgical therapy are scarce. To the best of our knowledge, a laparoscopic approach has not been published before. We investigated in one case of SANT the feasibility of a laparoscopic approach. Histological investigations confirmed the diagnosis of a SANT which was resected in toto. This report shows that the laparoscopic splenectomy is a feasible, safe and effective method for treatment of SANT.


Subject(s)
Histiocytoma, Benign Fibrous/surgery , Laparoscopy/methods , Splenectomy/methods , Splenic Diseases/surgery , Aged , Female , Histiocytoma, Benign Fibrous/diagnosis , Histiocytoma, Benign Fibrous/pathology , Humans , Magnetic Resonance Imaging , Spleen/pathology , Splenic Diseases/diagnosis , Splenic Diseases/pathology , Ultrasonic Surgical Procedures/methods , Ultrasonography
5.
Chirurg ; 82(1): 34-40, 2011 Jan.
Article in German | MEDLINE | ID: mdl-21104213

ABSTRACT

Surgery of the lower gastrointestinal tract includes segmental resections for benign colorectal diseases and radical resections for treating colorectal cancer performed under elective and emergency conditions. The most important part of the surgical procedure is the reconstruction of the physiological intestinal continuity by anastomosis. At present laparoscopic surgery has widened the array of different suturing and stapling techniques. The effectiveness of manual and stapled anastomoses depends on the expertise of the surgeon. However, skillful preparation of the hand-sutured technique is essential.


Subject(s)
Anastomosis, Surgical/methods , Colonic Diseases/surgery , Colorectal Neoplasms/surgery , Rectal Diseases/surgery , Anastomosis, Surgical/instrumentation , Anastomotic Leak/prevention & control , Colonic Pouches , Humans , Ileostomy/instrumentation , Ileostomy/methods , Surgical Instruments , Surgical Stapling/instrumentation , Surgical Stapling/methods , Suture Techniques/instrumentation
6.
Minerva Chir ; 65(5): 537-46, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21081865

ABSTRACT

The axillary nodal status is accepted as the most powerful prognostic tool available for early stage breast cancer. In the past radical removal of level I and level II lymph nodes at axillary node dissection (ALND) has been the most accurate method to assess nodal status, and it is the universal standard; however, it is associated with several adverse long-term sequelae. New diagnostic technologies have helped to individualize diagnostic evaluation and therapy of breast cancer thus improving efficacy and minimizing morbidity of treatment. Lymphatic mapping with sentinel lymph node biopsy has emerged as an effective and safe alternative to the ALND for detecting axillary metastases. Many issues such as indications or technique of performing sentinel node biopsy have been evaluated. Multiple studies now confirm that sentinel lymphadenectomy accurately stages the axilla and is associated with less morbidity than axillary dissection. Blue dye, radiocolloid, or both can be used to identify the sentinel node, and several injection techniques may be used successfully. Sentinel node biopsy is now minimally invasive, highly accurate method of axillary staging, and has replaced routine axillary lymph node dissection as the new standard of care in breast cancer. New technologies for axillary nodal staging include innovative imaging techniques such as single photon emission computerized tomography (SPECT) and modern histopathologic evaluation of sentinel nodes using molecular biologic approaches.


Subject(s)
Breast Neoplasms/pathology , Female , Forecasting , Humans , Lymphatic Metastasis , Neoplasm Staging , Sentinel Lymph Node Biopsy/trends
7.
Diabetologia ; 51(12): 2325-32, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18825362

ABSTRACT

AIMS/HYPOTHESIS: Reduced bioavailability of nitric oxide (NO) is a hallmark of diabetes mellitus-induced vascular complications. In the present study we investigated whether a pharmacological increase of endothelial NO synthase (eNOS) production can restore the impaired hindlimb flow in a rat model of severe diabetes. METHODS: A model of diabetes mellitus was induced in male Sprague-Dawley rats by a single injection of streptozotozin. Rats were treated chronically with the eNOS transcription enhancer AVE3085 (10 mg [kg body weight](-1) day(-1); p.o.) or vehicle for 48 days and compared with controls. Endothelial function and arterial BP were investigated in vivo using an autoperfused hindlimb model and TIP-catheter measurement, respectively. Protein production of eNOS, total and phosphorylated vasodilator-stimulated phosphoprotein (VASP) were assessed in their quadriceps muscle tissue, whereas cyclic GMP (cGMP) concentrations were assessed in blood plasma. RNA levels of intracellular and vascular cell adhesion molecules (ICAM-1 and VCAM-1) were measured by real-time PCR. RESULTS: Untreated diabetic rats showed significantly reduced quadriceps muscle contents of eNOS (-64%) and phosphorylated VASP (-26%) protein associated with impaired vascular function (maximum vasodilatation: -30%, p < 0.05) and enhanced production of ICAM-1 (+121%) and VCAM-1 (+156%). Chronic treatment with AVE3085 did not alter arterial BP or severe hyperglycaemia, but did lead to significantly increased production of eNOS (+95%), cGMP (+128%) and VASP phosphorylation (+65%) as well as to improved vascular function (+36%) associated with reduced production of ICAM-1 (-36%) and VCAM-1 (-58%). CONCLUSIONS/INTERPRETATION: In a rat model of severe diabetes, pharmacological enhancement of impaired eNOS production and NO-cGMP signalling by AVE3085 restores altered hindlimb blood flow and prevents vascular inflammation.


Subject(s)
Diabetes Complications/enzymology , Diabetes Mellitus, Experimental/enzymology , Hindlimb/enzymology , Nitric Oxide Synthase Type III/metabolism , Vascular Diseases/enzymology , Animals , Cell Adhesion Molecules/metabolism , Cyclic GMP/blood , Diabetes Complications/blood , Diabetes Complications/genetics , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/genetics , Gene Expression Regulation , Hindlimb/blood supply , Humans , Inflammation/blood , Inflammation/complications , Inflammation/enzymology , Inflammation/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Lipid Peroxidation , Male , Microfilament Proteins/metabolism , Muscles/metabolism , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type III/genetics , Phosphoproteins/metabolism , Rats , Rats, Sprague-Dawley , Streptozocin/pharmacology , Vascular Cell Adhesion Molecule-1/metabolism , Vascular Diseases/blood , Vascular Diseases/complications , Vascular Diseases/genetics
8.
Clin Nephrol ; 57(6): 414-20, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12078943

ABSTRACT

BACKGROUND: Plasma exchange improved the outcome of thrombotic thrombocytopenic purpura (TTP)/hemolytic uremic syndrome (HUS) of the adult markedly, but a high number of non-responders remain. Identifying these patients at an early stage would help to optimize therapy. AIM: determine the value of serologic measures in predicting the response to plasma exchange. MATERIAL AND METHODS: We performed a retrospective chart review of 30 patients with HUS/TTP of the adult treated with plasma exchange. According to the treatment protocol, a mean of 42 +/- 8.2 ml plasma per kilogram of body weight was exchanged daily for 3 days and continued every second day thereafter. Prior to each session, clinical status and serologic markers for hemolysis and kidney function were obtained. To assess the early individual response to plasma exchange, the decline of LDH from the first to the third cycle was calculated as: LDH concentration before the third session/LDH concentration before the first session (LDH ratio). RESULTS: During the observation period (median 195, range 6-1500 days), 80% of the patients responded to therapy with plasmapheresis. None of the serologic measures or clinical signs obtained before initiation of plasma exchange showed a significant correlation with the outcome. After 2 sessions of plasma exchange, only LDH and platelet level had improved markedly in responding patients. The LDH ratio was the best predictive marker for the individual response. An LDH ratio < 0.6 predicted a favorable outcome with a sensitivity of 0.96 and a specificity of 0.83. CONCLUSION: The LDH ratio might be a useful marker for separating patients responding to plasma exchange from those not responding at an early stage.


Subject(s)
Hemolytic-Uremic Syndrome/blood , Hemolytic-Uremic Syndrome/therapy , L-Lactate Dehydrogenase/blood , Plasma Exchange , Purpura, Thrombotic Thrombocytopenic/blood , Purpura, Thrombotic Thrombocytopenic/therapy , Adult , Biomarkers/blood , Female , Hemolytic-Uremic Syndrome/mortality , Humans , Male , Middle Aged , Outcome Assessment, Health Care , Predictive Value of Tests , Purpura, Thrombotic Thrombocytopenic/mortality , Reproducibility of Results , Retrospective Studies , Survival Rate , Time Factors
9.
Wien Klin Wochenschr ; 112(21): 939-41, 2000 Nov 10.
Article in English | MEDLINE | ID: mdl-11144010

ABSTRACT

The nephrotoxic side effects of cyclophilin-binding agents like cyclosporine A and tacrolimus are well characterized. In severe cases nephrotoxicity may profoundly deteriorate kidney function and even induce acute renal failure. In this report we describe the first case of excessive tacrolimus intoxication caused by hypothyroidism. The patient had undergone single-lung transplantation 6 months earlier, developed hypothyroidism, and was admitted with acute anuric renal failure. Thyroxin is a potent activator of the cytochrome P-450- CYP 3A enzyme system, which is crucial for tacrolimus metabolism. Hence, hypothyroidism reduces cytochrome P-450 activity and may result in drug accumulation. Rapid reversal of toxic drug levels could be achieved by reducing drug intake and increasing thyroxin levels by substitution therapy. In conclusion, it is important to consider thyroid function when prescribing medications with a narrow therapeutic range, which are metabolized by the cytochrome P-450 system such as tacrolimus, and the possible devastating effect of impaired drug metabolism during hypothyroidism.


Subject(s)
Acute Kidney Injury/chemically induced , Hypothyroidism/complications , Immunosuppressive Agents/poisoning , Lung Transplantation , Tacrolimus/poisoning , Acute Kidney Injury/diagnosis , Dose-Response Relationship, Drug , Fatal Outcome , Humans , Immunosuppressive Agents/administration & dosage , Male , Middle Aged , Risk Factors , Tacrolimus/administration & dosage , Thyroid Hormones/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...